LOINC
Version 2.73

LP64672-6Natalizumab AbActive

Description

LP64672-6   Natalizumab Ab
Drug therapy for MS - loses effectiveness when patients develop antibodies to the drug. Detecting the antibodies early allows healthcare providers the opportunity to prescribe alternative therapy and avoid the cost associated with failed therapy. Source: Regenstrief Institute

Basic Part Properties

Name
Natalizumab Ab
Type
Component
Created On
2007-07-17

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP64672-6

Language Variants Get Info

zh-CNChinese (China)
那他珠单抗抗体
Synonyms: Natalizumab Ab;Natalizumab 抗体;那他珠单抗 Ab